Precision BioSciences, Inc. - Common Stock (NQ:DTIL)

6.310 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Precision BioSciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update

March 27, 2024

From Precision BioSciences, Inc.

Via Business Wire

Earnings Scheduled For March 27, 2024 ↗

March 27, 2024

Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on revenue of $8.70 million.

Via Benzinga

Earnings Preview: Precision BioSciences ↗

March 26, 2024

Via Benzinga

Precision BioSciences to Report Fourth Quarter and Fiscal Year 2023 Results on March 27, 2024

March 20, 2024

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences Presents Preclinical Data Highlighting PBGENE-PMM as a Potential Therapy for Primary Mitochondrial Myopathy

March 19, 2024

From Precision BioSciences

Via Business Wire

Precision BioSciences Announces MHRA Approval for Partner iECURE to Expand Phase 1/2 Clinical Trial of ARCUS Gene Editing Program in OTC Deficiency

March 06, 2024

From Precision BioSciences, Inc.

Via Business Wire

Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

March 01, 2024

Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 01, 2024

Via Benzinga

SPX, Nasdaq Look To Continue Rally ↗

March 01, 2024

Fresh off a fourth-straight monthly win on Wall Street, stocks are on the rise as the week winds down.

Via Talk Markets

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 01, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

March 01, 2024

Pre-market stock movers are worth checking on Friday as investors prepare for the last day of trading this week with all of the latest news!

Via InvestorPlace

Precision BioSciences Announces $40.0 Million Offering of Common Stock and Warrants

March 01, 2024

From Precision BioSciences, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

February 29, 2024

Via Benzinga

Precision BioSciences Announces Proposed Public Offering of Common Stock and Warrants

February 29, 2024

From Precision BioSciences, Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 27, 2024

Via Benzinga

Precision BioSciences Announces Non-Exclusive Patent License Agreement with Caribou Biosciences

February 20, 2024

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences Receives Pre-IND Feedback from US FDA for PBGENE-HBV as it Advances Towards Clinical Readiness

February 14, 2024

From Precision BioSciences

Via Business Wire

Precision BioSciences Promotes Naresh Tanna to Vice President of Investor Relations

February 13, 2024

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences Receives Initial $7.5 Million Cash Payment and Equity Investment from TG Therapeutics for Azel-Cel in Treatment of Autoimmune Diseases

February 12, 2024

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences to Effect a Reverse Stock Split

February 09, 2024

From Precision BioSciences, Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 30, 2024

Via Benzinga

Why Is Multiple Sclerosis Focused TG Therapeutics Stock Trading Higher Today? ↗

January 10, 2024

TG Therapeutics Inc (NASDAQ: TGTX) reported preliminary BRIUMVI U.S.

Via Benzinga

Why Precision BioSciences Stock Is Up Today ↗

January 09, 2024

Precision BioSciences, Inc. (NASDAQ: DTIL) shares are trading higher Tuesday after the company announced it has signed a licensing agreement wit

Via Benzinga

Precision BioSciences Completes License Deal with TG Therapeutics for Cell Therapy Azer-Cel in Treatment of Autoimmune Diseases

January 09, 2024

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences Announces Approval of First Clinical Trial Application of ARCUS Gene Insertion Program by Partner iECURE

December 13, 2023

From Precision BioSciences, Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

December 05, 2023

Via Benzinga

Precision BioSciences Announces Publication in Nature Metabolism Supporting ARCUS® In Vivo Gene Editing as a Potentially Curative Treatment for Mitochondrial Diseases

December 04, 2023

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences to Present at Hep-DART 2023

November 30, 2023

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

November 28, 2023

From Precision BioSciences, Inc.

Via Business Wire

Sidoti Events, LLC’s Virtual November Micro-Cap Conference

November 14, 2023

Via ACCESSWIRE

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.